This site is intended for health professionals only

TOPRA: ‘Patients help benefit—risk decisions’

teaser

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Patient contributions to benefit-risk decisions and the transparency of the process were discussed at the recent joint meeting of The Organisation for Professionals in Regulatory Affairs (TOPRA) and the European Medicines Agency (EMA).

The annual meeting took place in the EMA building in Canary Wharf, London, from November 24






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x